Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on October 2, 2006

Hypertension. 2006
Published online before print October 2, 2006, doi: 10.1161/01.HYP.0000244688.45472.95
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/5/892    most recent
01.HYP.0000244688.45472.95v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pojoga, L.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pojoga, L.
Right arrow Articles by Williams, G. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Dietary Sodium
*High Blood Pressure
Related Collections
Right arrow Clinical genetics
Right arrow Clinical Studies
Right arrowRelated Article

Submitted on June 14, 2006
Revised on July 5, 2006

{beta}-2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension

Luminita Pojoga; Nikheel S. Kolatkar; Jonathan S. Williams; Todd S. Perlstein; Xavier Jeunemaitre; Nancy J. Brown; Paul N. Hopkins; Benjamin A. Raby; and Gordon H. Williams*

From the Division of Endocrinology, Diabetes, and Hypertension (L.P., N.S.K., J.S.W., G.H.W.), Division of Cardiology (T.S.P.), and Channing Laboratory (B.A.R.), Brigham and Women’s Hospital, and Harvard Medical School, Boston, Mass; Centre d’Investigation Clinique (X.J.), Departement de Genetique, Hôpital Européen Georges Pompidou, Paris, France; Departments of Medicine and Pharmacology (N.J.B.), Vanderbilt University Medical Center, Nashville, Tenn; and the Department of Medicine (P.N.H.), University of Utah School of Medicine, Salt Lake City.

* To whom correspondence should be addressed. E-mail: gwilliams{at}partners.org.

Abstract--Two genetic variants of the {beta}-2 adrenergic receptor, 46G>A and 79C>G, affect agonist-mediated receptor downregulation and vascular reactivity. We determined whether these variants were associated with hypertension, per se, blood pressure response to dietary sodium, 2 forms of salt-sensitive hypertension (low renin and nonmodulation), and the activity of the renin-angiotensin-aldosterone system. Included are 280 hypertensive and 65 normotensive white subjects who had the 2 {beta}-2 adrenergic receptor genotypes available. Of all subjects, 171 hypertensive and 48 normotensive subjects had complete data for intermediate phenotyping and blood pressure evaluation on high- and low-sodium balance. The {beta}-2 adrenergic receptor variants were not associated with hypertension per se. However, among hypertensive subjects, the change (from low to high sodium balance) in mean arterial pressure differed significantly by genotype and by diplotype. Compared with all of the other diplotypes combined, 46AA/79CC was associated with a greater change in blood pressure. Furthermore, this diplotype was associated with low-renin (LR) hypertension (identifying 32% of the LR hypertensives), higher plasma aldosterone, and lower plasma renin and serum potassium levels. In conclusion, the 46AA/79CC diplotype is associated with greater blood pressure response to dietary sodium and higher odds of LR hypertension. We propose that the mechanism for the observed association is inadequate suppression of aldosterone with salt intake, implicating the {beta}-2 adrenergic receptor in the regulation of aldosterone secretion. This hypothesis was confirmed in isolated glomerulosa cells, where {beta}-2 adrenergic receptor stimulation increased aldosterone secretion, whereas blockade reduced the stimulated aldosterone response. Importantly, this association could only be detected with an intermediate and not a distant phenotype.


Key words: bgr;-2 adrenergic receptor • hypertension • salt-sensitive hypertension • low-renin hypertension • single nucleotide polymorphisms • haplotypes • diplotypes


Related Article:

The Adrenergic Nervous System Conversing With the Adrenal Cortex: New Implications for Salt-Sensitive Hypertension
J. Howard Pratt
Hypertension 2006 48: 820-821. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
D. A. Calhoun and N. M. Kaplan
Is There an Unrecognized Epidemic of Primary Aldosteronism? (Pro)
Hypertension, September 1, 2007; 50(3): 447 - 453.
[Full Text] [PDF]


Home page
HypertensionHome page
J. H. Pratt
The Adrenergic Nervous System Conversing With the Adrenal Cortex: New Implications for Salt-Sensitive Hypertension
Hypertension, November 1, 2006; 48(5): 820 - 821.
[Full Text] [PDF]